CA Patent

CA2949910C — Modulators of intracellular chloride concentration for treating neurodegenerative diseases with parkinsonian syndromes

Assigned to B & A THERAPEUTICS · Expires 2022-09-13 · 4y expired

What this patent protects

The present invention relates to a composition for treating Neurodegenerative Diseases with Parkinsonian Syndromes in a subject in need thereof, wherein said composition comprises an effective amount of a modulator of a chloride transporter.

USPTO Abstract

The present invention relates to a composition for treating Neurodegenerative Diseases with Parkinsonian Syndromes in a subject in need thereof, wherein said composition comprises an effective amount of a modulator of a chloride transporter.

Drugs covered by this patent

Patent Metadata

Patent number: CA2949910C
Jurisdiction: CA
Classification: —
Expires: 2022-09-13
Drug substance claim: No
Drug product claim: No
Assignee: B & A THERAPEUTICS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.